HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma

Autor: Niens, Marijke, Jarrett, Ruth F., Hepkema, Bouke, Nolte, Ilja M., Diepstra, Arjan, Platteel, Mathieu, Kouprie, Niels, Delury, Craig P., Gallagher, Alice, Visser, Lydia, Poppema, Sibrand, te Meerman, Gerard J., van den Berg, Anke
Zdroj: In Blood 1 November 2007 110(9):3310-3315
Databáze: ScienceDirect